Escitalopram in Patients With Social Anxiety Disorder
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of escitalopram after 12 weeks of
treatment in patients with Social Anxiety Disorder (SAD), to evaluate proportion of patients
who respond to escitalopram during the treatment period, and to evaluate safety of
escitalopram.